ORIGINAL RESEARCH article

Front. Immunol.

Sec. Molecular Innate Immunity

Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1560391

This article is part of the Research TopicInnate and Adaptive Immunity of Normal and Adverse PregnancyView all articles

Single-cell RNA-sequencing highlights a curtailed NK cell function in post COVID-19 pregnant women

Provisionally accepted
Madhuri  S SalkerMadhuri S Salker1Haslinda  Abd AzizHaslinda Abd Aziz2Natalia  ProdanNatalia Prodan1Zhiqi  YangZhiqi Yang1Aditya  Kumar LankapalliAditya Kumar Lankapalli3Katrin  LazarKatrin Lazar1M Nasir  ShafieeM Nasir Shafiee2Ersoy  KocakErsoy Kocak1Harivignesh  GanesanHarivignesh Ganesan1Surya  Sekhar PalSurya Sekhar Pal1Omer  KhalidOmer Khalid1Norhana  Mohd KasimNorhana Mohd Kasim2Aida  KalokAida Kalok2Norashikin  Abdul FuadNorashikin Abdul Fuad4Alfred  Lennart BissingerAlfred Lennart Bissinger1Tina  GanzenmuellerTina Ganzenmueller1Thomas  IftnerThomas Iftner1Karl  Oliver KaganKarl Oliver Kagan1Stephan  OssowskiStephan Ossowski1Nicolas  CasadeiNicolas Casadei1DECOI  ConsortiumDECOI Consortium5Sara  Yvonne BruckerSara Yvonne Brucker1Olaf  RiessOlaf Riess1Yogesh  SinghYogesh Singh1*
  • 1University Hospital and Faculty of Medicine, University of Tübingen, Tübingen, Germany
  • 2Universiti Kebangsaan Malaysia Medical Center (UKMMC), Cheras, Malaysia
  • 3University of Oxford, Oxford, England, United Kingdom
  • 4Hospital Sungai Buloh, Sungai Buloh, Selangor Darul Ehsan, Malaysia
  • 5University of Bonn, Bonn, North Rhine-Westphalia, Germany

The final, formatted version of the article will be published soon.

During gestation the immune system undergoes dramatic remodelling to protect the maternal-fetal dyad from infections whilst also preventing fetal rejection. We investigated how SARS-CoV-2 modifies the immune landscape during infection and in recovered pregnant (post-COVID-19) women. Using two independent geographical cohorts, we identified that NK cells had a sustained reduction during active infection and after recovery quantified using flow cytometry. Further, our single-cell RNA sequencing (scRNA-seq) data revealed that infection with SARS-CoV-2 rewired the gene expression profile of NK, monocytes, CD4 + , CD8 + effector T cells and antibody producing B cells in convalescent pregnant women. Several gene pathways associated with cytotoxic function, interferon signalling type I & II, and pro-and anti-inflammatory functions in NK and CD8 + cytotoxic T cells were attenuated in recovered pregnant patients compared with healthy pregnancies. We validated our scRNA-seq of NK cells from convalescent pregnant women and confirmed that NK cells had diminished levels of cytotoxic proteins; perforin, CD122 and granzyme B. Overall, our study uncovers that SARS-CoV-2 infection deranges the adaptive immune response in pregnant women even after recovery and may contribute to post-COVID19 sequalae of symptoms.

Keywords: Pregnancy, COVID-19, PBMCs, NK cells and cytotoxic cells, ScRNA-seq

Received: 14 Jan 2025; Accepted: 16 May 2025.

Copyright: © 2025 Salker, Abd Aziz, Prodan, Yang, Lankapalli, Lazar, Shafiee, Kocak, Ganesan, Pal, Khalid, Kasim, Kalok, Fuad, Lennart Bissinger, Ganzenmueller, Iftner, Kagan, Ossowski, Casadei, Consortium, Brucker, Riess and Singh. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Yogesh Singh, University Hospital and Faculty of Medicine, University of Tübingen, Tübingen, Germany

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.